Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(8):577; doi:10.1093/jnci/djk188
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Savage, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Savage, L.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

MEMO TO THE MEDIA

Press Release

Long-term Use of Adult-Strength Aspirin Linked to a Moderate Decreased Cancer Risk

Liz Savage

jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute

The first 10% of the full text of this article appears below.

A daily dose of adult-strength aspirin may modestly reduce cancer risk in populations with high rates of colorectal, prostate, and breast cancer if taken for at least five years.

The Women's Health Study trial recently reported that long-term use of low-dose aspirin (about 100mg every other day) does not reduce a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

More Aspirin for Less Cancer?
María Elena Martínez and E. Robert Greenberg
J Natl Cancer Inst 2007 99: 582-583. [Extract] [Full Text] [PDF]

A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Eric J. Jacobs, Michael J. Thun, Elizabeth B. Bain, Carmen Rodriguez, S. Jane Henley, and Eugenia E. Calle
J Natl Cancer Inst 2007 99: 608-615. [Abstract] [Full Text] [PDF]